General Information of the Compound
Compound ID
CP0060921
Compound Name
US10065963, 32c
    Show/Hide
Synonyms
(4R)-4-(3-((1S)-1-(4-Amino-3-methyl-1H-pyrazolo(3,4-d)pyrimidin-1-yl)ethyl)-5-chloro-2-ethoxy-6-fluorophenyl)pyrrolidin-2-one
(4R)-4-{3-[(1S)-1-(4-amino-3-methyl-1H-pyrazolo[3,4-d]pyrimidin-1-yl)ethyl]-5-chloro-2-ethoxy-6-fluorophenyl}pyrrolidin-2-one
(R)-4-(3-((S)-1-(4-amino-3-methyl-1H-pyrazolo[3,4-d]pyrimidin-1-yl)ethyl)-5-chloro-2-ethoxy-6-fluorophenyl)pyrrolidin-2-one
1426698-88-5
1426698-88-5 (free base)
2-Pyrrolidinone, 4-(3-((1S)-1-(4-amino-3-methyl-1H-pyrazolo(3,4-d)pyrimidin-1-yl)ethyl)-5-chloro-2-ethoxy-6-fluorophenyl)-, (4R)-
BDBM272573
CHEMBL4297615
CS-0033435
D11437
DB14867
EX-A2638
HY-109068
INCB-050465
INCB-050465 free base
INCB050465
INCB050465 free base
OS7097575K
Parsaclisib
Parsaclisib (USAN/INN)
Parsaclisib [INN]
Parsaclisib [USAN:INN]
Parsaclisib [USAN]
Parsaclisib free base
SCHEMBL14736228
UNII-OS7097575K
US10065963, 32c
WHO 10589
    Show/Hide
Structure
Formula
C20H22ClFN6O2
Molecular Weight
432.887
Canonical SMILES
CCOc1c(cc(Cl)c(F)c1[C@@H]1CNC(=O)C1)[C@H](C)n1nc(C)c2c(N)ncnc12
    Show/Hide
InChI
InChI=1S/C20H22ClFN6O2/c1-4-30-18-12(6-13(21)17(22)16(18)11-5-14(29)24-7-11)10(3)28-20-15(9(2)27-28)19(23)25-8-26-20/h6,8,10-11H,4-5,7H2,1-3H3,(H,24,29)(H2,23,25,26)/t10-,11-/m0/s1
    Show/Hide
InChIKey
ZQPDJCIXJHUERQ-QWRGUYRKSA-N
CAS
1426698-88-5
Physicochemical Property
logP
3.12092
Rotatable Bonds
5
Heavy Atom Count
30
Polar Areas
107.95
Hydrogen Bond Donor Count
2
Hydrogen Bond Acceptor Count
7
Complexity
30

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 86677874
ChEMBL ID
CHEMBL4297615
DrugBank ID
DB14867
Table of Molecular Bioactivities Related to the Compound
Cell Viability or Cytotoxicity Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000178 SU-DHL-6 Homo sapiens (Human)  1
1
IC50 = 1.6 nM
   TI
   LI
   LO
   TS
Clinical Information about the Compound
Drug 1 ( Parsaclisib )
Drug Name Parsaclisib
Company Incyte
Indication
Follicular lymphoma
Phase 2
Target(s)
PI3-kinase delta (PIK3CD)
Inhibitor